- Previous Close
0.0005 - Open
0.0005 - Bid --
- Ask --
- Day's Range
0.0005 - 0.0005 - 52 Week Range
0.0005 - 0.0025 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
1.393M - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date Mar 6, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. BPH Global Ltd was incorporated in 1984 and is headquartered in Melbourne, Australia.
www.scu.com.sg--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: USZ0.F
View MorePerformance Overview: USZ0.F
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: USZ0.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: USZ0.F
View MoreValuation Measures
Market Cap
1.39M
Enterprise Value
1.53M
Trailing P/E
0.73
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-117.38%
Return on Equity (ttm)
--
Revenue (ttm)
160.9k
Net Income Avi to Common (ttm)
-1.52M
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
218.46k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-136.8k